Expression and suppressive effects of interleukin-19 on vascular smooth muscle cell pathophysiology and development of intimal hyperplasia

American Journal of Pathology

Volumn 173, Issue 3, 2008, Pages 901-909

  Tian, Ying ^a   Sommerville, Laura J ^a   Cuneo, Anthony ^a   Kelemen, Sheri E ^a   Autieri, Michael V ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; INTERLEUKIN 19; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 5; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; AUTOCRINE EFFECT; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; GENE TRANSFER; HUMAN; HUMAN CELL; NONHUMAN; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 51349096030     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.080163     Document Type: Article

References (27)

1. Welt FGP, Rogers C: Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 2002, 22:1769-1776
2. Ventura HO, Mehra MR, Smart FW: Cardiac allograft vasculopathy: current concepts. Am Heart J 1995, 129:791-798
3. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809
4. Raines EW, Ferri N: Cytokines affecting endothelial and smooth muscle cells in vascular disease. J Lipid Res 2005, 46:1081-1092
5. Singer CA Sonemany S, Baker KJ, Gerthoffer WT: Synthesis of immune modulators by smooth muscles. BioEssays 2004, 26:646-655
6. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB: Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004, 22:929-979
7. Oral HB, Kotenko SV, Yilmaz M, Mani O, Zumkehr J, Blaser K, Akdis CA, Akdis M: Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26. Eur J Immunol 2006, 36:380-388
8. Gallagher G, Eskdale E, Jordan W, Peat J, Campbell J, Boniotto M, Lennon GP, Dickensheets H, Donnelly RP: Human interleukin-19 and its receptor: a potential role in the induction of Th2 responses. Int Immunopharmacol 2004, 4:615-626
9. Jordan W, Eskdale J, Boniotto M, Lennon GP, Peat J, Campbell JDM, Gallagher G: Human IL-19 regulates immunity through auto-induction of IL-19 and production of IL-10. Eur J Immunol. 2005, 35:1576-1582
10. Kelemen SE, Eisen HJ, Autieri MV: Expression of the FAST-1 transcription factor in coronary artery transplant vasculopathy and activated vascular smooth muscle cells. J Heart Lung Transplant 2005, 24:46-50
11. Chen X, Kelemen SE, Autieri MV: AIF-1 expression modulates proliferation of human vascular smooth muscle cells by autocrine expression of G-CSF. Arterioscler Thromb Vasc Biol 2004, 21:1-7
12. Autieri MV, Feuerstein GZ, Yue T-L, Ohlstein E, Douglas SA: Use of differential display to identify differentially expressed mRNAs induced by rat carotid artery balloon angioplasty. Lab Invest 1995, 72:656-661
13. Schwartz RS, Chu A, Edwards WD, Srivatsa SS, Simari RD, Isner JM, Holmes Jr DR: A proliferation analysis of arterial neointimal hyperplasia: lessons for antiproliferative restenosis therapies. Int J Cardiol 1996, 53:71-80
14. Schwartz SM, deBlois D, O'Brien ER: The intima. Soil for atherosclerosis and restenosis. Circ Res 1995, 77:445-465
15. Mazighi M, Pelle A, Gonzalez W, Mtairag el M, Philippe M, Henin D, Michel JB, Feldman LJ: IL-10 inhibits vascular smooth muscle cell activation in vitro and in vivo. Am J Physiol 2004, 287:H866-H871
16. Paukku K, Silvennoinen O: STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5. Cytokine Growth Factor Rev 2004, 15:435-455
17. Darnell Jr JE: STATs and gene regulation. Science 1997, 277:1630-1635
18. Cooney RN: Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway. Shock 2002, 17:83-90
19. Chen XP, Losman JA, Rothman P: SOCS proteins, regulators of intracellular signaling. Immunity 2000, 13:287-290
20. Bardwell AJ, Flatauer LJ, Matsukuma K, Thorner J, Bardwell LA: Conserved docking site in MEKs mediates high-affinity binding to MAP kinases and cooperates with a scaffold protein to enhance signal transmission. J Biol Chem 2001, 276:10374-10386
21. Parrish-Novak J, Xu W, Brender T, Yao L, Jones C, West J, Brandt C, Jelinek L, Madden K, McKernan PA, Foster DC, Jaspers S, Chandrasekher YA: Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological function. J Biol Chem 2002, 277:47517-47523
22. Murray PJ: STAT3-mediated anti-inflammatory signaling. Biochem Soc Trans 2006, 34:1028-1031
23. Tang J, Raines EW: Are suppressors of cytokine signaling proteins recently identified in atherosclerosis possible therapeutic targets? Trends Cardiovasc Med 2005, 15:243-249
24. Fujimoto M, Naka T: Regulation of cytokine signaling by SOCS family molecules. Trends Immunol 2003, 24:659-666
25. Mooney RA, Senn J, Cameron S, Inamdar N, Boivin LM, Shang Y, Furlanetto RW: Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance. J Biol Chem 2001, 276:25889-25893
26. Kim S, Izumi Y, Yano M, Hamaguchi A, Miura K, Yamanaka A, Miyazaki H, Iwao H: Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery. Circulation 1998, 97:1731-1737
27. Ohashi N, Matsumori A, Furukawa Y, Ono K, Okada M, Iwasaki A, Miyamoto T, Nakano A, Sasayama S: Role of p38 mitogen-activated protein kinase in neointimal hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol 2000, 20:2521-2526